Experienced in Dehydration

Ting G. Luo

No.17 Hongqi Avenue, 
Ganzhou, CN 
Experienced in Dehydration
No.17 Hongqi Avenue, 
Ganzhou, CN 
OverviewLocationsClinical Research

Overview

Ting Luo practices in Ganzhou, China. Ms. Luo is rated as an Experienced expert by MediFind in the treatment of Dehydration. Her top areas of expertise are Breast Cancer, Obesity, Hyperaldosteronism, Mastectomy, and Endoscopy.

Her clinical research consists of co-authoring 693 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Dehydration.

Gender
Female

Locations

No.17 Hongqi Avenue, Ganzhou, 341000, China
Other Locations
No.197 Ruijin 2nd Road, Shanghai, 200025, China
149 Dalian Road, Zunyi, 563003, China
2nd Ruijin Road 197, Shanghai, 200025, China
118 Jiahang Road, 314-001, Jiaxing, China
345 Lingling Road, Shanghai, 200032, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
Enrollment Status: Terminated
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3

693 Total Publications

Buchwald-Hartwig aminated pyrene-heterocycles with host-guest-enhanced NIR phosphorescence: DFT-guided design toward breast cancer imaging probes.
Buchwald-Hartwig aminated pyrene-heterocycles with host-guest-enhanced NIR phosphorescence: DFT-guided design toward breast cancer imaging probes.
Journal: Physical chemistry chemical physics : PCCP
Published: December 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Luo's expertise for a condition
ConditionClose
      View All 96 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile